20,638
Total Claims
$4.5M
Drug Cost
1,255
Beneficiaries
$3,608
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+137%
Cost per patient vs peers
$3,608 vs $1,524 avg
Opioid Prescribing
0.1%
Opioid Rate
19
Opioid Claims
$183
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 15,957 claims · $460K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,211 | $1.0M |
| Sacubitril/Valsartan | 929 | $855K |
| Dapagliflozin Propanediol | 420 | $457K |
| Evolocumab | 504 | $324K |
| Riociguat | 24 | $321K |
| Rivaroxaban | 206 | $178K |
| Alirocumab | 232 | $131K |
| Ticagrelor | 172 | $95K |
| Dronedarone Hcl | 54 | $70K |
| Sitagliptin Phosphate | 77 | $58K |
| Semaglutide | 56 | $58K |
| Empagliflozin | 48 | $51K |
| Icosapent Ethyl | 133 | $48K |
| Ranolazine | 203 | $42K |
| Metoprolol Succinate | 1,186 | $27K |
Prescribing Profile
Patient Profile
74
Avg Age
50%
Female
1.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data